ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 746351 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 746351; 2) Community: the network communities that were significantly associated with the response to NSC 746351; 3) Molecule: the relationships between components within communities and NSC 746351; 4) MDR: the compounds that were significantly associated with the NSC 746351.

NSC Compound Enrichment Correlation
NSC 726444 4,11-bis[[2-(methylamino)ethyl]amino]-3-[(dimethylamino)meth yl]-1H-naphtho[2,3-f]indole-5,10-dione 0.00013525639843218 0.49019025
NSC 747292 Null 0.000135256398432181 0.5207017
NSC 755417 Null 0.000135256398432181 0.77719087
NSC 132483 Aminopterin Derivative 0.000216242727122389 0.50380011
NSC 678925 1-Phenazinecarboxamide, N-[2-(dimethylamino)ethyl]- 9-fluoro-, monohydrochloride 0.000216242727122389 0.53579917
NSC 744209 Null 0.000216242727122389 0.72513507
NSC 718781 Erlotinib hydrochloride 0.000281397700245213 -0.34379413
NSC 726217 Combretastatin A4-analogue 0.000281397700245213 0.33974709
NSC 724037 Null 0.000285499812229898 0.30929119
NSC 728856 5,6-Dihydro-6-[3-(3-imidazolylpropyl)amino-1-propyl]-5,11-di oxo-11H-indeno[1,2-c]isoquinoline dihdrochloride 0.000285499812229898 0.49583065
Total:78  Current:1    [First] [Prev] [Next] [Last]